| Ronald A Weisner, MD | |
|
3100 Tongass Ave, Ketchikan, AK 99901-5746 | |
| (907) 228-7660 | |
| (907) 228-8336 |
| Full Name | Ronald A Weisner |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 3100 Tongass Ave, Ketchikan, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770752503 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 6248 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ronald A Weisner, MD 3100 Tongass Ave, Ketchikan, AK 99901-5746 Ph: (907) 228-7660 | Ronald A Weisner, MD 3100 Tongass Ave, Ketchikan, AK 99901-5746 Ph: (907) 228-7660 |
News Archive
A reformulated version of an anti-HIV gel developed for vaginal use was found safe and acceptable by HIV-negative men and women who used it rectally, according to a Phase I clinical trial published today in PLOS ONE.
Hospital for Special Surgery (HSS) plans to host a two-day international Osteoarthritis Summit in June 2011. The Hospital, internationally recognized for its leadership in the fields of orthopedics and rheumatology, will bring together, for the first time, a truly comprehensive multidisciplinary group of world renowned scientists, thought-leaders and industry representatives from the United States, Canada, and Europe, to discuss all aspects of OA and develop a consensus document on future directions for OA research, prevention and treatment.
Scientists in the United States and India have successfully modified the precursor to one of the drugs used to treat tuberculosis, an important first step toward new drugs that can transcend antibiotic resistance issues that experts consider a serious threat to global health.
GenMark Diagnostics, Inc. announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock. GenMark is a Delaware corporation and, in connection with the offering, will become the parent holding company of Osmetech, plc.
UCB and the Inflammatory Bowel Disease Working Group today announced the five recipients of the 2010 Research Awards in Inflammatory Bowel Disease for Gastroenterology Fellows, each of whom will receive a one-year $40,000 research grant for their original clinical or basic research.
› Verified 9 days ago
Dr. Mahija Mungara, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2960 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-4900 Fax: 800-852-3264 | |
Wynelle R Snow, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 21 Jefferson St, Suite 201, Ketchikan, AK 99901 Phone: 907-220-9948 Fax: 907-220-9947 | |
Mr. Victor Chen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3100 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-7660 Fax: 907-228-8549 | |
Dr. Bryan Cothren, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3100 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-7660 Fax: 907-228-8549 |